AM Investment Strategies LLC Has $423,000 Holdings in CVS Health Co. (NYSE:CVS)

AM Investment Strategies LLC decreased its position in shares of CVS Health Co. (NYSE:CVS) by 49.7% during the 4th quarter, HoldingsChannel.com reports. The fund owned 9,422 shares of the pharmacy operator’s stock after selling 9,328 shares during the period. AM Investment Strategies LLC’s holdings in CVS Health were worth $423,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. MidAtlantic Capital Management Inc. acquired a new stake in shares of CVS Health during the 3rd quarter worth approximately $25,000. Ridgewood Investments LLC boosted its position in shares of CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 450 shares in the last quarter. Livelsberger Financial Advisory acquired a new stake in shares of CVS Health during the 3rd quarter worth approximately $31,000. Legacy Investment Solutions LLC acquired a new stake in shares of CVS Health during the 3rd quarter worth approximately $31,000. Finally, Reston Wealth Management LLC acquired a new stake in shares of CVS Health during the 3rd quarter worth approximately $32,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Up 1.6 %

Shares of NYSE CVS opened at $54.71 on Friday. The stock has a market capitalization of $68.84 billion, a P/E ratio of 13.88, a P/E/G ratio of 0.80 and a beta of 0.59. The company has a 50-day moving average price of $51.21 and a 200-day moving average price of $56.22. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same quarter in the previous year, the firm posted $2.21 earnings per share. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. On average, equities research analysts forecast that CVS Health Co. will post 5.22 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be paid a $0.665 dividend. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 4.86%. CVS Health’s dividend payout ratio is presently 67.51%.

Wall Street Analyst Weigh In

Several equities analysts recently commented on CVS shares. TD Cowen increased their price objective on shares of CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, November 25th. Evercore ISI increased their price objective on shares of CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. UBS Group increased their price objective on shares of CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a research note on Thursday, November 7th. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a research note on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $68.71.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.